SEARCH:
Print Text size Comment
Email this
Clinical Trials Update: Nov. 4, 2009

The form has errors highlighted in red, please review these entries and try again!



(Separate multiple addresses with commas)




privacy policy | visitor agreement

Clinical Trials Update: Nov. 4, 2009



HealthDay News

Wednesday, November 04, 2009

Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Hepatitis C

This study will evaluate the safety and effectiveness of an investigational medication to treat chronic hepatitis C genotype 1 infection.

The research site is in Los Angeles, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.

-----

Osteoarthritis of the Hip or Knee

This study will evaluate a medication designed to ease osteoarthritis pain in the hip or knee. You must be aged 18 to 78 to qualify.

The research site is in Atlanta, Ga.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/osteoarthritis.aspx.

-----

Ankle Sprain

If you have hurt your ankle within the past 48 hours, you may qualify for this study of an investigational pain patch. Participants will have a 50/50 chance of receiving the actual patch or a placebo patch.

The research site is in Dallas, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/sprain.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

INSIDE LIFE & MARQUEE

Church Notes
Faith and fellowship

Calendar follows local congregations' many activities.


Over 6 million items at your fingertips! Enter a keyword or highlight a category to search or browse at your leisure!
Search by Category

Rocky Mount Telegram | Weather | Sports | Life | Business News | Opinions | Classifieds | Sitemap
Rocky Mount Cars | Rocky Mount Jobs | Rocky Mount Real Estate

Copyright 2009 Rocky Mount Telegram All rights reserved. - Rocky Mount Telegram - Our Partners

By using this service, you accept the terms of our visitor agreement and privacy policy. About our ads.
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ